+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Perinatal Infections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Perinatal Infections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Perinatal Infections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 187 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5950243
Free Webex Call
10% Free customization
Description Jump to:

Hospitals & Clinics is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Perinatal Infections Market, valued at USD 1.60 Billion in 2024, is projected to experience a CAGR of 5.30% to reach USD 2.18 Billion by 2030. The Global Perinatal Infections Market focuses on diagnostic and therapeutic solutions for infections caused by viruses or bacteria transmitted from a mother to her fetus during gestation or childbirth. Market expansion is substantially driven by the increasing global prevalence of these infections, alongside rising healthcare expenditure and heightened public awareness concerning maternal and child health. Further growth is supported by continuous technological advancements in diagnostic methodologies and treatment modalities, facilitating earlier detection and more effective interventions.

Key Market Drivers

The Global Perinatal Infections Market is significantly shaped by sustained technological advancements in diagnostics and treatment. Innovations in diagnostic platforms are continuously enhancing the precision and accessibility of early detection for perinatal infections. This includes the development of non-invasive prenatal tests, which allow for screening of complex fetal genetic conditions with reduced risk. For instance, according to Natera, in August 2025, their Fetal Focus test, a noninvasive prenatal test for inherited conditions, was launched, supported by data from a clinical trial that initiated in 2023 and had enrolled approximately 1,300 participants. These diagnostic breakthroughs enable earlier and more accurate identification of infections, facilitating timely intervention and improving outcomes for both mother and child.

Key Market Challenges

The scarcity of adequately skilled healthcare professionals capable of providing accurate diagnosis and comprehensive treatment for complex perinatal conditions significantly impedes the growth of the Global Perinatal Infections Market. This shortage directly limits the effective deployment and utilization of innovative diagnostic technologies and therapeutic solutions. When there are insufficient trained personnel, particularly those specializing in infectious diseases, the ability to promptly and accurately identify perinatal infections is compromised. This often leads to delayed treatment initiation, reduced efficacy of available interventions, and poorer maternal and neonatal outcomes.

Key Market Trends

The growing adoption of personalized medicine approaches represents a pivotal trend reshaping the Global Perinatal Infections Market by moving beyond standardized treatments to highly individualized care. This trend emphasizes tailoring diagnostic and therapeutic interventions based on a mother's unique genetic profile, microbial resistance patterns, and immune response, aiming to optimize outcomes for both mother and child.

Such customization drives demand for advanced molecular diagnostics capable of identifying specific pathogens and host genetic predispositions with high precision. According to the Personalized Medicine Coalition, the FDA approved 18 new personalized medicines in 2024, constituting 38% of all newly approved therapeutic molecular entities across various treatment areas. Companies are increasingly collaborating in this space; Roche and Janssen Biotech Inc. joined forces in February 2023 to develop personalized and targeted therapies alongside companion diagnostics, signaling a strategic focus on this tailored medical paradigm.

Key Market Players Profiled:

  • Merck KGaA
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories, Inc
  • Hologic Inc.
  • Gilead Sciences, Inc.
  • Emcure Pharmaceuticals Limited.
  • Cipla Inc.
  • Bausch Health Companies Inc
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.

Report Scope:

In this report, the Global Perinatal Infections Market has been segmented into the following categories:

By Infection Type:

  • Cytomegalovirus Infection
  • Enterovirus Infection
  • Genital Herpes
  • Gonorrhoea
  • Human Immunodeficiency Virus
  • Listeriosis Lymphocytic Choriomeningitis Virus
  • Rubella
  • Syphilis
  • Varicella
  • Others

By Treatment:

  • Antibiotics
  • Antiviral
  • Antiretroviral
  • Others

By Diagnosis:

  • Maternal Test
  • Neonatal Test
  • Others

By End user:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Perinatal Infections Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Perinatal Infections Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Infection Type (Cytomegalovirus Infection, Enterovirus Infection, Genital Herpes, Gonorrhoea, Human Immunodeficiency Virus, Listeriosis Lymphocytic Choriomeningitis Virus, Rubella, Syphilis, Varicella, Others)
5.2.2. By Treatment (Antibiotics, Antiviral, Antiretroviral, Others)
5.2.3. By Diagnosis (Maternal Test, Neonatal Test, Others)
5.2.4. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Perinatal Infections Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Infection Type
6.2.2. By Treatment
6.2.3. By Diagnosis
6.2.4. By End user
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Perinatal Infections Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Infection Type
6.3.1.2.2. By Treatment
6.3.1.2.3. By Diagnosis
6.3.1.2.4. By End user
6.3.2. Canada Perinatal Infections Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Infection Type
6.3.2.2.2. By Treatment
6.3.2.2.3. By Diagnosis
6.3.2.2.4. By End user
6.3.3. Mexico Perinatal Infections Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Infection Type
6.3.3.2.2. By Treatment
6.3.3.2.3. By Diagnosis
6.3.3.2.4. By End user
7. Europe Perinatal Infections Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Infection Type
7.2.2. By Treatment
7.2.3. By Diagnosis
7.2.4. By End user
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Perinatal Infections Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Infection Type
7.3.1.2.2. By Treatment
7.3.1.2.3. By Diagnosis
7.3.1.2.4. By End user
7.3.2. France Perinatal Infections Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Infection Type
7.3.2.2.2. By Treatment
7.3.2.2.3. By Diagnosis
7.3.2.2.4. By End user
7.3.3. United Kingdom Perinatal Infections Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Infection Type
7.3.3.2.2. By Treatment
7.3.3.2.3. By Diagnosis
7.3.3.2.4. By End user
7.3.4. Italy Perinatal Infections Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Infection Type
7.3.4.2.2. By Treatment
7.3.4.2.3. By Diagnosis
7.3.4.2.4. By End user
7.3.5. Spain Perinatal Infections Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Infection Type
7.3.5.2.2. By Treatment
7.3.5.2.3. By Diagnosis
7.3.5.2.4. By End user
8. Asia-Pacific Perinatal Infections Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Infection Type
8.2.2. By Treatment
8.2.3. By Diagnosis
8.2.4. By End user
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Perinatal Infections Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Infection Type
8.3.1.2.2. By Treatment
8.3.1.2.3. By Diagnosis
8.3.1.2.4. By End user
8.3.2. India Perinatal Infections Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Infection Type
8.3.2.2.2. By Treatment
8.3.2.2.3. By Diagnosis
8.3.2.2.4. By End user
8.3.3. Japan Perinatal Infections Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Infection Type
8.3.3.2.2. By Treatment
8.3.3.2.3. By Diagnosis
8.3.3.2.4. By End user
8.3.4. South Korea Perinatal Infections Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Infection Type
8.3.4.2.2. By Treatment
8.3.4.2.3. By Diagnosis
8.3.4.2.4. By End user
8.3.5. Australia Perinatal Infections Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Infection Type
8.3.5.2.2. By Treatment
8.3.5.2.3. By Diagnosis
8.3.5.2.4. By End user
9. Middle East & Africa Perinatal Infections Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Infection Type
9.2.2. By Treatment
9.2.3. By Diagnosis
9.2.4. By End user
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Perinatal Infections Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Infection Type
9.3.1.2.2. By Treatment
9.3.1.2.3. By Diagnosis
9.3.1.2.4. By End user
9.3.2. UAE Perinatal Infections Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Infection Type
9.3.2.2.2. By Treatment
9.3.2.2.3. By Diagnosis
9.3.2.2.4. By End user
9.3.3. South Africa Perinatal Infections Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Infection Type
9.3.3.2.2. By Treatment
9.3.3.2.3. By Diagnosis
9.3.3.2.4. By End user
10. South America Perinatal Infections Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Infection Type
10.2.2. By Treatment
10.2.3. By Diagnosis
10.2.4. By End user
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Perinatal Infections Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Infection Type
10.3.1.2.2. By Treatment
10.3.1.2.3. By Diagnosis
10.3.1.2.4. By End user
10.3.2. Colombia Perinatal Infections Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Infection Type
10.3.2.2.2. By Treatment
10.3.2.2.3. By Diagnosis
10.3.2.2.4. By End user
10.3.3. Argentina Perinatal Infections Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Infection Type
10.3.3.2.2. By Treatment
10.3.3.2.3. By Diagnosis
10.3.3.2.4. By End user
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Perinatal Infections Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Merck KGaA
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Beckman Coulter Inc.
15.3. Bio-Rad Laboratories, Inc
15.4. Hologic Inc.
15.5. Gilead Sciences, Inc.
15.6. Emcure Pharmaceuticals Limited.
15.7. Cipla Inc.
15.8. Bausch Health Companies Inc
15.9. Johnson & Johnson
15.10. Teva Pharmaceutical Industries Ltd.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Perinatal Infections market report include:
  • Merck KGaA
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories, Inc
  • Hologic Inc.
  • Gilead Sciences, Inc.
  • Emcure Pharmaceuticals Limited.
  • Cipla Inc.
  • Bausch Health Companies Inc
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages187
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.18 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Perinatal Infections - Global Strategic Business Report - Product Image

Perinatal Infections - Global Strategic Business Report

  • Report
  • 397 Pages
  • Global
From
Clinical Perinatal Software Market Size, Share & Trends Analysis Report By Product, By Deployment Model, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Clinical Perinatal Software Market Size, Share & Trends Analysis Report By Product, By Deployment Model, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Clinical Perinatal Software Market Size, Share & Trends Analysis Report By Product (Integrated and Standalone), By Deployment Model (On-premise and Cloud), By Application, By End Use, By Regional Outlook and Forecast, 2024 - 2031 - Product Image

Clinical Perinatal Software Market Size, Share & Trends Analysis Report By Product (Integrated and Standalone), By Deployment Model (On-premise and Cloud), By Application, By End Use, By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • 265 Pages
  • Global
From
Clinical Perinatal Software Market - Global Forecast 2025-2032 - Product Image

Clinical Perinatal Software Market - Global Forecast 2025-2032

  • Report
  • 182 Pages
  • Global
From
Clinical Perinatal Software - Global Strategic Business Report - Product Image

Clinical Perinatal Software - Global Strategic Business Report

  • Report
  • 470 Pages
  • Global
From

About the Perinatal Infections Market

Within the domain of Women's Health, the market for Perinatal Infections encompasses a range of products, services, and solutions aimed at the prevention, diagnosis, and treatment of infections that can be transmitted from mother to baby during pregnancy, childbirth, or immediately postpartum. This market is driven by the need to manage conditions such as HIV, hepatitis, syphilis, and other bacterial, viral, or parasitic infections, which can have serious implications on the health of both the mother and the newborn. Products in this niche include diagnostic tests, vaccines, antibiotics, antivirals, and educational resources for healthcare providers and expectant parents. The market is further supported by public health initiatives, research and development activities by pharmaceutical and biotech companies, and evolving guidelines that promote screening and treatment to prevent mother-to-child transmission of these infections. Several companies are active in the Perinatal Infections market within Women's Health. These include Pfizer, Merck & Co., Roche Diagnostics, Johnson & Johnson, and Gilead Sciences. These companies are engaged in the development and marketing of various pharmaceuticals, vaccines, and diagnostic tools aimed at managing and preventing perinatal infections. They are also involved in extensive research to innovate and enhance the effectiveness of their offerings in the face of evolving pathogens and resistance patterns. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.